Chemotherapy in the management of brain metastases: the emerging role of fotemustine for patients with melanoma and NSCLC.
about
Advances in treatment of brain metastases from primary non-small cell lung cancerThe role of the cancer stem cell marker CD271 in DNA damage response and drug resistance of melanoma cells.Ipilimumab and immune-mediated adverse events: a case report of anti-CTLA4 induced ileitis.B-Raf inhibitor vemurafenib in combination with temozolomide and fotemustine in the killing response of malignant melanoma cells.Immunological effects of chemotherapy and radiotherapy against brain tumors.Management of intracranial melanomas in the era of precision medicine.Factor associated with failure to administer subsequent treatment after progression in the first-line chemotherapy in EGFR-mutant non-small cell lung cancer: Okayama Lung Cancer Study Group experience.The search for a melanoma-tailored chemotherapy in the new era of personalized therapy: a phase II study of chemo-modulating temozolomide followed by fotemustine and a cooperative study of GOIM (Gruppo Oncologico Italia Meridionale).
P2860
Q27022452-8DD37CCA-EA04-4F85-9C31-A21129417794Q30837718-D18499EC-EE3D-4758-9791-6CA63BC0637FQ35150452-60D56071-0999-4AF2-BFF7-9241FDC0EBA2Q38923467-C99ED005-0270-4DF8-8F29-6423013660C0Q38947116-ADA0A6A3-85E4-4DF6-A8E7-570C4A273E2FQ44959749-A30CCF4C-ABE1-4324-A96C-D49835945763Q51748170-B9CC87D8-A903-48A4-819E-4DDF851FF433Q54974198-FF19D42C-BE14-4D75-B7D8-0B4C1AD82799
P2860
Chemotherapy in the management of brain metastases: the emerging role of fotemustine for patients with melanoma and NSCLC.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Chemotherapy in the management ...... ients with melanoma and NSCLC.
@en
type
label
Chemotherapy in the management ...... ients with melanoma and NSCLC.
@en
prefLabel
Chemotherapy in the management ...... ients with melanoma and NSCLC.
@en
P2860
P50
P1476
Chemotherapy in the management ...... tients with melanoma and NSCLC
@en
P2093
Amalia Luce
Silvia Zappavigna
P2860
P304
P356
10.1517/14740338.2013.789017
P407
P577
2013-04-08T00:00:00Z